COMPUMEDICS LIMITED — Regulatory Filings 2009

Aug 17, 2009

ASX / MEDIA RELEASE

==> picture [79 x 82] intentionally omitted <==

COMPUMEDICS LIMITED AUDIO STREAM

COMPUMEDICS LIMITED (CMP) provides the opportunity to listen to an audio broadcast with Mr. David Burton, Chairman and Boardroomradio in a presentation titled "Business update August 2009" .

To listen , simply click on the link below:

http://www.brr.com.au/event/59367

The presentation details are as follows:

Questions and answers on the current business and strategy prior to the release of the Company’s Appendix 4E to the ASX

• Presented by Mr. David Burton, Executive Chairman Compumedics Group

• Wednesday 19 August 2009 at 10:30am AEST

To listen, simply click on the Windows Media Player, QuickTime or MP3 icon.

Additionally, the presentation can be accessed at www.boardroomradio.com where it will also be archived for future on-demand listening – if you miss the live presentation, you can log on later to hear the news.

Yours faithfully

==> picture [94 x 74] intentionally omitted <==

David Lawson Company Secretary

For further information, please contact:

David Burton Executive Chairman & CEO Compumedics Tel: +61 3 8420 7300

ASX Release

12 March 2009

About Compumedics Compumedics Limited, founded in 1987, is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology. In 1987 Compumedics established Asia Pacific’s first fully computerised sleep laboratory. Compumedics holds 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological, and Doppler blood-flow diagnostic monitoring devices. In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia and offices in the United States, and Europe the products are distributed in over 50 countries. In 1998 Compumedics was awarded the overall Australian Exporter of the Year. In 2000 Compumedics was listed on the Australian Stock Exchange. In 2002 , Compumedics acquired US-based Neuroscan - the world's leading supplier of instruments for brain-research. In the US - the world's largest medical device market - Neuroscan holds around 90% of the market for brain-research products. In 2003 Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy. In 2004 , Compumedics acquired German-based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-vascular diagnostic fields. In 2006 , Compumedics was awarded the Frost and Sullivan Technology Leadership award for the innovative Somté recorder product. In 2007 , Compumedics and Chairman were inducted into the Victorian Manufacturing Hall of Fame. In 2008 the DWL division received the top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics the Compumedics sales have grown more than 4 fold from $9 million (1999) to $39 million (2008). www.compumedics.com

ASX Release

12 March 2009